
Reset all filters
01 4Diprospan
Betamethasone Dipropionate, Betamethasone Sodium Phosphate
Main Therapeutic Indication : Rheumatology
Currency : USD
2021 Revenue in Millions : 125
2020 Revenue in Millions : 118
Growth (%) : 6
Betamethasone Dipropionate, Betamethasone Sodium Phosphate
Main Therapeutic Indication : Rheumatology
Currency : USD
2022 Revenue in Millions : 122
2021 Revenue in Millions : 125
Growth (%) : -2
Betamethasone Dipropionate, Betamethasone Sodium Phosphate
Main Therapeutic Indication : Rheumatology
Currency : USD
2023 Revenue in Millions : 91
2022 Revenue in Millions : 122
Growth (%) : -25
Betamethasone Dipropionate, Betamethasone Sodium Phosphate
Main Therapeutic Indication : Immunology
Currency : USD
2024 Revenue in Millions : 139
2023 Revenue in Millions : 91
Growth (%) : 53